The California Academy of Sciences Inducts ASPET Member Bruce Hammock
Bruce Hammock, PhD, has been inducted as a Fellow of the California Academy of Sciences. Dr. Hammock, an ASPET member since 2003, is a Distinguished Professor at the University of California (UC), Davis. An expert in chemistry, toxicology, biochemistry and entomology, he holds a joint appointment with the Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center.
Dr. Hammock has been internationally recognized for discovering a new group of human chemical mediators that have contributed to treating arthritis, cancer and Alzheimer’s Disease. He also co-discovered the human enzyme, Soluble Epoxide Hydrolase, a key regulatory enzyme involved in the metabolism of fatty acids.
Hammock is a member of the ASPET Division for Toxicology, and in 2014, he received ASPET’s Bernard B. Brodie Award in Drug Metabolism and Disposition.
MSU Recognizes ASPET Member Carolina Restini for Excellence in Teaching
Michigan State University (MSU) recently awarded Carolina Restini, PharmD, PhD, the Department of Pharmacology and Toxicology’s Award for Excellence in Teaching. Dr. Restini is recognized for exemplifying a commitment to excellence in teaching and implementing creative and effective ways to foster student learning. She received this honor as a faculty member who has earned the respect of medical students, peers and staff for her devotion to and skill in teaching.
Restini is an Assistant Professor at MSU, College of Osteopathic Medicine, where she teaches basic and clinical pharmacology. Dr. Restini develops research projects and investigations considering the humanistic aspects of therapeutics. She joined ASPET in 2019 and is a member of the ASPET Divisions for Pharmacology Education, Cardiovascular Pharmacology, and Translational and Clinical Pharmacology.
ASPET Fellow Dr. V. Craig Jordan Receives the Sir Henry Wellcome Gold Medal
ASPET Fellow Dr. V. Craig Jordan has been awarded the Sir Henry Wellcome Gold Medal from the British Pharmacological Society, for his outstanding lifetime research commitment to pharmacology. He has focused his 50-year career on the mechanisms of estrogen-regulated breast cancer growth and resistance to anti-estrogen therapies.
Jordan helped to revolutionize women’s health with an in-depth translational research program that initially took a failed contraceptive ICI46,474, and developed the successful research strategy for the medicine that became tamoxifen. This would later be used for the treatment and prevention of breast cancer.
Jordan went on to discover a new group of medicines referred to as Selective Estrogen Receptor Modulators (SERMs). Five SERMs that switch on or switch off sites around a woman’s body are FDA-approved with discovery origins in Jordan’s laboratory.
Dr. Jordan was selected as an ASPET Fellow (FASPET) in 2022 and has been a member since 1981. He has received numerous awards from the Society, including the ASPET Award for Experimental Therapeutics (1993), the Goodman and Gilman Award (2012), and the Reynold Spector Award (2019). He joined the British Pharmacological Society in 1976 and was selected as an inaugural Fellow in 2004.
